Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $152.44 million. The enterprise value is $89.29 million.

Market Cap	152.44M
Enterprise Value	89.29M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.53 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	6.53M
Shares Outstanding	6.53M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	2.53%
Owned by Institutions (%)	23.10%
Float	2.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.78
P/TBV Ratio	0.78
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	-14.73%
Revenue Per Employee	n/a
Profits Per Employee	-$1.53M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +224.44% in the last 52 weeks. The beta is 1.74, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+224.44%
50-Day Moving Average	43.34
200-Day Moving Average	19.61
Relative Strength Index (RSI)	35.53
Average Volume (20 Days)	155,128

Short Selling Information

The latest short interest is 375,997, so 5.76% of the outstanding shares have been sold short.

Short Interest	375,997
Short Previous Month	334,867
Short % of Shares Out	5.76%
Short % of Float	15.73%
Short Ratio (days to cover)	2.29

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-70.82M
Pretax Income	-123.32M
Net Income	-75.17M
EBITDA	-66.85M
EBIT	-70.82M
Earnings Per Share (EPS)	-$11.56

Full Income Statement

Balance Sheet

The company has $148.77 million in cash and $85.62 million in debt, giving a net cash position of $63.16 million or $9.68 per share.

Cash & Cash Equivalents	148.77M
Total Debt	85.62M
Net Cash	63.16M
Net Cash Per Share	$9.68
Equity (Book Value)	195.02M
Book Value Per Share	29.98
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.05%
Shareholder Yield	-0.05%
Earnings Yield	-49.31%
FCF Yield	n/a

Analyst Forecast

The average price target for Instil Bio is $100.33, which is 329.50% higher than the current price. The consensus rating is "Buy".

Price Target	$100.33
Price Target Difference	329.50%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a